Literature DB >> 16584513

Physiological and catecholamine response to sympathetic stimulation in turner syndrome.

Nehama Zuckerman-Levin1, Oren Zinder, Avital Greenberg, Moshe Levin, Giris Jacob, Ze'ev Hochberg.   

Abstract

OBJECTIVE: Women with Turner syndrome have increased heart rate and high blood pressure (BP), and have been described as having high tolerance for emotional stress. We hypothesized that women with Turner syndrome have reduced catecholaminergic and physiological response to sympathetic stimulation, and that changes in BP and heart rate are related to their catecholamine response to sympathetic stimulation. DESIGN AND PATIENTS: Ten young women with Turner syndrome, age 17-34 years were the subjects of this study. Their response to sympathetic stimulation was compared to a group of 10 age-matched healthy women. MEASUREMENTS: After a period of 30 min resting, subjects and controls were subjected to an escalating series of sympathetic stimulation: orthostatic, cold pressor and exercise, and their plasma catecholamines and haemodynamic response were monitored and compared to resting levels.
RESULTS: Resting heart rate was higher in Turner syndrome patients at 83 +/- 9 beats per min (bpm, mean +/- SD), as compared to controls (74 +/- 10 bpm, P < 0.05). Their supine BP was also higher at 122 +/- 9/84 +/- 6 vs. 106 +/- 11/70 +/- 9 mmHg (P < 0.02/< 0.02). The corresponding resting norepinephrine, but not epinephrine, was higher in Turner syndrome patients (2.54 +/- 1.09 nmol/l) as compared to controls (1.69 +/- 0.55 nmol/l, P < 0.02). In response to orthostatic stimulation and cold pressor test the systolic, but not the diastolic BP or heart rate, increased in Turner syndrome patients but not in the control group (P < 0.01). The change in blood catecholamine levels was comparable in both groups. Their physiological response to exercise was normal. Yet, the exercise-induced surge of norepinephrine and epinephrine in Turner syndrome patients was lower (P < 0.02).
CONCLUSIONS: Turner syndrome is associated with dysregulation of the sympathetic nervous system (SNS), leading to tachycardia and high BP, increased resting norepinephrine levels, and a greater tolerance of the cathecholamine response to exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584513     DOI: 10.1111/j.1365-2265.2006.02483.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Left atrial remodelling among Turner syndrome patients: novel insights from non-invasive 3D echocardiography.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Mohamed Abd El Rahman; Anna-Maria Jung; Michael Zemlin; Tilman R Rohrer; Rita Schuck
Journal:  Quant Imaging Med Surg       Date:  2022-05

2.  Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension.

Authors:  Katya De Groote; Daniël Devos; Koen Van Herck; Laurent Demulier; Wesley Buysse; Jean De Schepper; Daniël De Wolf
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

3.  Two-dimensional speckle tracking of the abdominal aorta: a novel approach to evaluate arterial stiffness in patients with Turner syndrome.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Anna-Maria Jung; Tilman R Rohrer; Mohamed Abd El Rahman
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

4.  Delayed β-cell response and glucose intolerance in young women with Turner syndrome.

Authors:  Britta E Hjerrild; Jens J Holst; Claus B Juhl; Jens S Christiansen; Ole Schmitz; Claus H Gravholt
Journal:  BMC Endocr Disord       Date:  2011-03-15       Impact factor: 2.763

5.  Prolonged QT interval and cardiac arrest after a single dose of amiodarone in a woman with Turner's syndrome.

Authors:  Dorte Guldbrand Nielsen; Jens Cosedis Nielsen; Christian Trolle; Claus Højbjerg Gravholt; Niels Holmark Andersen
Journal:  Clin Case Rep       Date:  2017-01-21

6.  A value-based healthcare approach: Health-related quality of life and psychosocial functioning in women with Turner syndrome.

Authors:  Allard T van den Hoven; Lidia R Bons; Ramon H M Dykgraaf; Arianne B Dessens; Hester Pastoor; Laura C G de Graaff; Mick R Metselaar; Annemiek Kneppers-Swets; Isabella Kardys; Hester Mijnarends; Frank Zweerus; Jan A Hazelzet; Elisabeth M W J Utens; Annemien E van den Bosch; Jolien W Roos-Hesselink
Journal:  Clin Endocrinol (Oxf)       Date:  2020-02-18       Impact factor: 3.478

7.  Assessment of left ventricular myocardial work in Turner syndrome patients: insights from the novel non-invasive pressure-strain loop analysis method.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Anna-Maria Jung; Michael Zemlin; Tilman R Rohrer; Mohamed Abd El Rahman
Journal:  Quant Imaging Med Surg       Date:  2020-01

8.  Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.

Authors:  Christian Trolle; Kristian H Mortensen; Lisbeth N Pedersen; Agnethe Berglund; Henrik K Jensen; Niels H Andersen; Claus H Gravholt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

9.  The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes.

Authors:  Yael Lebenthal; Sigal Levy; Efrat Sofrin-Drucker; Nessia Nagelberg; Naomi Weintrob; Shlomit Shalitin; Liat de Vries; Ariel Tenenbaum; Moshe Phillip; Liora Lazar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-09       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.